title: Association of the glycoxidative stress marker pentosidine with equine laminitis.
abstract: Ponies suffering from recurrent episodes of laminitis when grazed at pasture (pasture-associated laminitis) exhibit phenotypes similar to those associated with human metabolic syndrome. In humans, evidence suggests that the obesity-related morbidities associated with metabolic syndrome, including diabetes and cardiovascular disease, are caused by an increase in the production of advanced glycoxidation end-products (AGEs). These end-products have been recognised as putative pro-inflammatory mediators and are considered a 'risk factor' for human health. However, the evaluation of AGEs in laminitic ponies has not been explored. The aim of this study was to compare plasma concentrations of the AGE pentosidine (PENT) in ponies presenting with clinical features of equine metabolic syndrome (EMS) with a history of recent laminitis and/or showing signs of laminitis at the time of sampling (LP) with those with no prior history of clinical laminitis (NL). Age, body condition score (BCS) and bodyweight were recorded and blood samples collected for the measurement of plasma concentrations of PENT, glucose, insulin, triglycerides (TG), non-esterified fatty acids (NEFA) and cortisol. Insulin sensitivity was assessed by the reciprocal of the square root of insulin (RISQI) and the insulin:glucose ratio. Plasma PENT concentrations were twofold higher (P<0.005) in LP than in NL ponies. Significant (P<0.05) correlations were also evident between PENT and insulin, RISQI, TG and age. These preliminary findings are consistent with the hypothesis that glycoxidation in laminitis is associated with EMS.
authors.affiliation: Department of Animal Production, Epidemiology and Ecology, Faculty of Veterinary Medicine, University of Turin, Italy. emanuela.valle@unito.it
authors.forename: E
authors.initials: E
authors.lastname: Valle
authors.forename: D
authors.initials: D
authors.lastname: Storace
authors.forename: R
authors.initials: R
authors.lastname: Sanguineti
authors.forename: R
authors.initials: R
authors.lastname: Carter
authors.forename: P
authors.initials: P
authors.lastname: Odetti
authors.forename: R
authors.initials: R
authors.lastname: Geor
authors.forename: D
authors.initials: D
authors.lastname: Bergero
mesh_terms: D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism; D015415:Biomarkers; D005534:Foot Diseases / Q000097:blood / Q000378:metabolism / Q000662:veterinary*; D006724:Hoof and Claw / Q000378:metabolism*; D006734:Horse Diseases / Q000097:blood / Q000378:metabolism*; D006736:Horses; D007249:Inflammation / Q000097:blood / Q000378:metabolism / Q000662:veterinary*; D008239:Lysine / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism
chemical_list: D015415:Biomarkers; D001120:Arginine; C062187:pentosidine; D008239:Lysine